drugset / Trial / NCT01777347

Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis

NCT01777347

Phase 3 Completed 778 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether nebulized hypertonic saline solution reduces the admission rate 48 hours after initial treatment in the emergency department, when compared to normal saline solution (control).

Timeline

Start
2012-10
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 4 ml Inhaled

Indications